"Fructose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding.
| Descriptor ID |
D005632
|
| MeSH Number(s) |
D09.947.875.359.250 D09.947.875.465.354
|
| Concept/Terms |
Apir Levulosa- Apir Levulosa
- Levulosa, Apir
- Levulosa Mein
- Plast Apyr Levulosa Mein
- Levulosa Ibys
|
Below are MeSH descriptors whose meaning is more general than "Fructose".
Below are MeSH descriptors whose meaning is more specific than "Fructose".
This graph shows the total number of publications written about "Fructose" by people in this website by year, and whether "Fructose" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 3 | 0 | 3 |
| 2006 | 2 | 0 | 2 |
| 2007 | 4 | 1 | 5 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 0 | 2 |
| 2010 | 3 | 0 | 3 |
| 2011 | 3 | 0 | 3 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fructose" by people in Profiles.
-
Silberstein SD. Topiramate in Migraine Prevention: A 2016 Perspective. Headache. 2017 Jan; 57(1):165-178.
-
Mintzer S, Skidmore CT, Rankin SJ, Chervoneva I, Pequinot E, Capuzzi DM, Sperling MR. Conversion from enzyme-inducing antiepileptic drugs to topiramate: effects on lipids and C-reactive protein. Epilepsy Res. 2012 Jan; 98(1):88-93.
-
Ali II, Herial NA, Orris M, Horrigan T, Tietjen GE. Migraine prophylaxis with topiramate and bone health in women. Headache. 2011 Apr; 51(4):613-6.
-
Diener HC, Holle D, Dodick D. Treatment of chronic migraine. Curr Pain Headache Rep. 2011 Feb; 15(1):64-9.
-
Silberstein SD. Predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramate. Cephalalgia. 2010 Nov; 30(11):1283.
-
Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study. Cephalalgia. 2011 Jan; 31(1):18-30.
-
Marmura MJ, Hopkins M, Andrel J, Young WB, Biondi DM, Rupnow MF, Armstrong RB. Electronic medical records as a research tool: evaluating topiramate use at a headache center. Headache. 2010 May; 50(5):769-78.
-
Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. Headache. 2009 Sep; 49(8):1153-62.
-
Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Clin Ther. 2009 Mar; 31(3):542-59.
-
Piovesan EJ, Randunz V, Utiumi M, Lange MC, Kowacs PA, Mulinari RA, Oshinsky M, Vital M, Sereniki A, Fernandes AF, e Silva LL, Werneck LC. Influence of NMDA and non-NMDA antagonists on acute and inflammatory pain in the trigeminal territory: a placebo control study. Arq Neuropsiquiatr. 2008 Dec; 66(4):837-43.